ID

23065

Description

L-Theanine in the Management of Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT00372151

Lien

https://clinicaltrials.gov/show/NCT00372151

Mots-clés

  1. 21/06/2017 21/06/2017 -
Téléchargé le

21 juin 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Schizophrenia NCT00372151

Eligibility Schizophrenia NCT00372151

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 18-60 years, men or women
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
dsm-iv criteria for schizophrenia or schizoaffective disorder
Description

Schizophrenia | Schizoaffective Disorder

Type de données

boolean

Alias
UMLS CUI [1]
C0036341
UMLS CUI [2]
C0036337
at least 4 on the clinical global impression scale
Description

Clinical Global Impression Questionnaire

Type de données

boolean

Alias
UMLS CUI [1]
C3639708
at least two weeks of ongoing treatment with current antipsychotic agents.
Description

Antipsychotic Agents

Type de données

boolean

Alias
UMLS CUI [1]
C0040615
ability and willingness to sign an informed consent form for participation in the study.
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
evidence of serious neurologic or endocrine disorder, for example severe head trauma, seizure disorder, dementia, cushings disease, or thyroid disorder, mental retardation, alcohol or drug abuse.
Description

Nervous system disorder Serious | Endocrine System Disease Serious | Craniocerebral Trauma Severe | Epilepsy | Dementia | Cushing's disease | Thyroid Diseases | Mental Retardation | Substance Use Disorders

Type de données

boolean

Alias
UMLS CUI [1,1]
C0027765
UMLS CUI [1,2]
C0205404
UMLS CUI [2,1]
C0014130
UMLS CUI [2,2]
C0205404
UMLS CUI [3,1]
C0018674
UMLS CUI [3,2]
C0205082
UMLS CUI [4]
C0014544
UMLS CUI [5]
C0497327
UMLS CUI [6]
C0221406
UMLS CUI [7]
C0040128
UMLS CUI [8]
C0025362
UMLS CUI [9]
C0038586
renal disease
Description

Kidney Diseases

Type de données

boolean

Alias
UMLS CUI [1]
C0022658
hepatic dysfunction
Description

Liver Dysfunction

Type de données

boolean

Alias
UMLS CUI [1]
C0086565
pregnant women
Description

Pregnancy

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
patients receiving mood stabilizing medications.
Description

Mood stabilizing agent

Type de données

boolean

Alias
UMLS CUI [1]
C1533054

Similar models

Eligibility Schizophrenia NCT00372151

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age 18-60 years, men or women
boolean
C0001779 (UMLS CUI [1])
Schizophrenia | Schizoaffective Disorder
Item
dsm-iv criteria for schizophrenia or schizoaffective disorder
boolean
C0036341 (UMLS CUI [1])
C0036337 (UMLS CUI [2])
Clinical Global Impression Questionnaire
Item
at least 4 on the clinical global impression scale
boolean
C3639708 (UMLS CUI [1])
Antipsychotic Agents
Item
at least two weeks of ongoing treatment with current antipsychotic agents.
boolean
C0040615 (UMLS CUI [1])
Informed Consent
Item
ability and willingness to sign an informed consent form for participation in the study.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Nervous system disorder Serious | Endocrine System Disease Serious | Craniocerebral Trauma Severe | Epilepsy | Dementia | Cushing's disease | Thyroid Diseases | Mental Retardation | Substance Use Disorders
Item
evidence of serious neurologic or endocrine disorder, for example severe head trauma, seizure disorder, dementia, cushings disease, or thyroid disorder, mental retardation, alcohol or drug abuse.
boolean
C0027765 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0014130 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0018674 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0014544 (UMLS CUI [4])
C0497327 (UMLS CUI [5])
C0221406 (UMLS CUI [6])
C0040128 (UMLS CUI [7])
C0025362 (UMLS CUI [8])
C0038586 (UMLS CUI [9])
Kidney Diseases
Item
renal disease
boolean
C0022658 (UMLS CUI [1])
Liver Dysfunction
Item
hepatic dysfunction
boolean
C0086565 (UMLS CUI [1])
Pregnancy
Item
pregnant women
boolean
C0032961 (UMLS CUI [1])
Mood stabilizing agent
Item
patients receiving mood stabilizing medications.
boolean
C1533054 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial